☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the quarterly period ended December 31, 2016
|
|
|
|
OR
|
|
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
DELAWARE
|
|
51-0539828
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
1 Bella Drive
Westminster, MA
|
|
01473
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Yes
|
☒
|
No
|
☐
|
Yes
|
☒
|
No
|
☐
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
Non-Accelerated Filer
|
☐
|
Smaller reporting company
|
☒
|
Yes
|
☐
|
No
|
☒
|
|
|
Page
|
PART I.
|
FINANCIAL INFORMATION
|
|
ITEM 1.
|
FINANCIAL STATEMENTS
|
|
|
CONDENSED CONSOLIDATED BALANCE SHEETS
|
|
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
|
|
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
|
ITEM 2.
|
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
ITEM 4.
|
CONTROLS AND PROCEDURES
|
|
PART II.
|
OTHER INFORMATION
|
|
ITEM 1.
|
LEGAL PROCEEDINGS
|
|
ITEM 6.
|
EXHIBITS
|
|
|
SIGNATURES
|
|
EXHIBIT INDEX
|
|
|
|
|
|
December 31,
2016
|
March 31,
2016
|
||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash
|
$
|
3,794,773
|
$
|
1,332,166
|
||||
Accounts receivable, less allowance for doubtful accounts of $0 at
December 31, 2016 and March 31, 2016
|
771,202
|
2,022,480
|
||||||
Costs on uncompleted contracts, in excess of progress billings
|
3,050,850
|
2,395,642
|
||||||
Inventories - raw materials
|
124,394
|
128,595
|
||||||
Other current assets
|
363,523
|
530,808
|
||||||
Total current assets
|
8,104,742
|
6,409,691
|
||||||
Property, plant and equipment, net
|
4,747,890
|
4,814,184
|
||||||
Deferred income taxes
|
684,270
|
684,270
|
||||||
Other noncurrent assets, net
|
123,900
|
176,344
|
||||||
Total assets
|
$
|
13,660,802
|
$
|
12,084,489
|
||||
|
||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY:
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$
|
548,759
|
$
|
996,065
|
||||
Accrued expenses
|
1,195,317
|
1,804,485
|
||||||
Income taxes payable
|
5,589
|
9,032
|
||||||
Advanced claims payment
|
--
|
507,835
|
||||||
Billings on uncompleted contracts, in excess of related costs
|
663,158
|
1,629,018
|
||||||
Current portion of long-term debt
|
696,245
|
953,106
|
||||||
Total current liabilities
|
3,109,068
|
5,899,541
|
||||||
Long-term debt, net
|
5,041,868
|
3,735,410
|
||||||
Deferred income taxes
|
684,270
|
684,270
|
||||||
Noncurrent accrued expenses
|
22,580
|
37,097
|
||||||
Commitments and contingent liabilities (see Note 14)
|
||||||||
Stockholders' Equity:
|
||||||||
Common stock - par value $.0001 per share, 90,000,000 shares authorized,
28,824,593 shares issued and outstanding at December 31, 2016, and
27,324,593 shares issued and outstanding at March 31, 2016
|
2,882
|
2,732
|
||||||
Additional paid in capital
|
8,188,284
|
7,094,749
|
||||||
Accumulated other comprehensive income
|
19,249
|
21,568
|
||||||
Accumulated deficit
|
(3,407,399
|
)
|
(5,390,878
|
)
|
||||
Total stockholders' equity
|
4,803,016
|
1,728,171
|
||||||
Total liabilities and stockholders' equity
|
$
|
13,660,802
|
$
|
12,084,489
|
|
Three Months Ended
December 31,
|
Nine Months Ended
December 31,
|
||||||||||||||
|
2016
|
2015
|
2016
|
2015
|
||||||||||||
Net sales
|
$
|
5,318,610
|
$
|
3,506,560
|
$
|
13,619,578
|
$
|
11,985,422
|
||||||||
Cost of sales
|
3,266,721
|
2,434,900
|
8,558,680
|
8,223,349
|
||||||||||||
Gross profit
|
2,051,889
|
1,071,660
|
5,060,898
|
3,762,073
|
||||||||||||
Selling, general and administrative
|
1,955,093
|
768,220
|
3,582,856
|
2,482,465
|
||||||||||||
Gain from claims assignment settlement
|
(1,122,287
|
)
|
--
|
(1,122,287
|
)
|
--
|
||||||||||
Income from operations
|
1,219,083
|
303,440
|
2,600,329
|
1,279,608
|
||||||||||||
Other, net
|
1,130
|
471
|
8,705
|
1,561
|
||||||||||||
Interest expense
|
(207,521
|
)
|
(291,908
|
)
|
(583,999
|
)
|
(808,209
|
)
|
||||||||
Total other expense, net
|
(206,391
|
)
|
(291,437
|
)
|
(575,294
|
)
|
(806,648
|
)
|
||||||||
Income before income taxes
|
1,012,692
|
12,003
|
2,025,035
|
472,960
|
||||||||||||
Income tax expense
|
20,598
|
--
|
41,556
|
--
|
||||||||||||
Net income
|
$
|
992,094
|
$
|
12,003
|
$
|
1,983,479
|
$
|
472,960
|
||||||||
Other comprehensive (loss) income, before tax:
|
||||||||||||||||
Foreign currency translation adjustments
|
(1,095
|
)
|
(1,135
|
)
|
(2,319
|
)
|
217
|
|||||||||
Other comprehensive (loss) income, before tax
|
(1,095
|
)
|
(1,135
|
)
|
(2,319
|
)
|
217
|
|||||||||
Income tax expense on other comprehensive (loss) income
|
--
|
--
|
--
|
--
|
||||||||||||
Other comprehensive (loss) income, net of tax
|
(1,095
|
)
|
(1,135
|
)
|
(2,319
|
)
|
217
|
|||||||||
Comprehensive income
|
$
|
990,999
|
$
|
10,868
|
$
|
1,981,160
|
$
|
473,177
|
||||||||
Net income per share (basic)
|
$
|
0.03
|
$
|
0.00
|
$
|
0.07
|
$
|
0.02
|
||||||||
Net income per share (diluted)
|
$
|
0.03
|
$
|
0.00
|
$
|
0.07
|
$
|
0.02
|
||||||||
Weighted average number of shares outstanding (basic)
|
28,156,115
|
27,324,593
|
27,602,775
|
26,084,080
|
||||||||||||
Weighted average number of shares outstanding (diluted)
|
28,873,237
|
27,509,980
|
28,261,110
|
26,210,206
|
|
Nine Months Ended
December 31,
|
|||||||
|
2016
|
2015
|
||||||
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||
Net income
|
$
|
1,983,479
|
$
|
472,960
|
||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Depreciation
|
519,114
|
582,628
|
||||||
Amortization of debt issue costs
|
129,383
|
219,876
|
||||||
Stock based compensation expense
|
1,093,685
|
51,100
|
||||||
Benefit from contract loss adjustments
|
(320,900
|
)
|
(111,958
|
)
|
||||
Gain from claims assignment settlement – noncash portion
|
(507,835
|
)
|
--
|
|||||
Changes in operating assets and liabilities:
|
||||||||
Accounts receivable
|
1,251,278
|
59,798
|
||||||
Costs on uncompleted contracts, in excess of progress billings
|
(547,812
|
)
|
(789,764
|
)
|
||||
Inventories – raw materials
|
4,201
|
(13,738
|
)
|
|||||
Other current assets
|
167,263
|
(110,355
|
)
|
|||||
Other noncurrent assets and liabilities
|
(30,961
|
)
|
--
|
|||||
Accounts payable
|
(447,306
|
)
|
(438,486
|
)
|
||||
Accrued expenses
|
(412,198
|
)
|
67,709
|
|||||
Accrued taxes
|
(3,443
|
)
|
--
|
|||||
Advanced claims payment
|
--
|
507,835
|
||||||
Billings on uncompleted contracts, in excess of related costs
|
(965,860
|
)
|
(124,327
|
)
|
||||
Net cash provided by operating activities
|
1,912,088
|
373,278
|
||||||
|
||||||||
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||
Purchases of property, plant and equipment
|
(452,820
|
)
|
(192,215
|
)
|
||||
Net cash used in investing activities
|
(452,820
|
)
|
(192,215
|
)
|
||||
|
||||||||
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||
Deferred loan costs
|
(159,137
|
)
|
--
|
|||||
Borrowings of long-term debt
|
6,227,500
|
--
|
||||||
Repayment of long-term debt
|
(5,064,745
|
)
|
(700,174
|
)
|
||||
Net cash provided by (used in) financing activities
|
1,003,618
|
(700,174
|
)
|
|||||
Effect of exchange rate on cash
|
(279
|
)
|
(913
|
)
|
||||
Net increase (decrease) in cash
|
2,462,607
|
(520,024
|
)
|
|||||
Cash, beginning of period
|
$
|
1,332,166
|
$
|
1,336,325
|
||||
Cash, end of period
|
$
|
3,794,773
|
$
|
816,301
|
||||
|
||||||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION
|
||||||||
Cash paid during the period for:
|
||||||||
Interest
|
$
|
692,541
|
$
|
525,421
|
||||
Income taxes
|
$
|
45,000
|
$
|
--
|
|
December 31,
2016
|
March 31,
2016
|
||||||
Land
|
$
|
110,113
|
$
|
110,113
|
||||
Building and improvements
|
3,252,908
|
3,252,908
|
||||||
Machinery equipment, furniture and fixtures
|
8,843,922
|
8,418,243
|
||||||
Equipment under capital leases
|
65,568
|
65,568
|
||||||
Total property, plant and equipment
|
12,272,511
|
11,846,832
|
||||||
Less: accumulated depreciation
|
(7,524,621
|
)
|
(7,032,648
|
)
|
||||
Total property, plant and equipment, net
|
$
|
4,747,890
|
$
|
4,814,184
|
|
December 31,
2016
|
March 31,
2016
|
||||||
Cost incurred on uncompleted contracts, beginning balance
|
$
|
5,491,605
|
$
|
4,068,488
|
||||
Total cost incurred on contracts during the period
|
9,186,786
|
12,783,323
|
||||||
Less cost of sales, during the period
|
(8,558,680
|
)
|
(11,360,206
|
)
|
||||
Cost incurred on uncompleted contracts, ending balance
|
$
|
6,119,711
|
$
|
5,491,605
|
||||
|
||||||||
Billings on uncompleted contracts, beginning balance
|
$
|
3,095,963
|
$
|
2,060,244
|
||||
Total billings incurred on contracts, during the period
|
13,592,476
|
17,889,671
|
||||||
Less: Contracts recognized as revenue, during the period
|
(13,619,578
|
)
|
(16,853,952
|
)
|
||||
Billings on uncompleted contracts, ending balance
|
$
|
3,068,861
|
$
|
3,095,963
|
||||
|
||||||||
Cost incurred on uncompleted contracts, ending balance
|
$
|
6,119,711
|
$
|
5,491,605
|
||||
Billings on uncompleted contracts, ending balance
|
3,068,861
|
3,095,963
|
||||||
Costs incurred on uncompleted contracts, in excess of progress billings
|
$
|
3,050,850
|
$
|
2,395,642
|
|
December 31,
2016
|
March 31,
2016
|
||||||
Prepaid insurance
|
$
|
205,472
|
$
|
236,300
|
||||
Payments advanced to suppliers
|
127,744
|
182,305
|
||||||
Collateral deposits
|
--
|
85,252
|
||||||
Other
|
30,307
|
26,951
|
||||||
Total
|
$
|
363,523
|
$
|
530,808
|
|
December 31,
2016
|
March 31,
2016
|
||||||
Fixed assets held for sale
|
$
|
123,900
|
$
|
123,900
|
||||
Other
|
--
|
52,444
|
||||||
Total
|
$
|
123,900
|
$
|
176,344
|
|
December 31,
2016
|
March 31,
2016
|
||||||
Accrued compensation
|
$
|
745,657
|
$
|
872,114
|
||||
Provision for contract losses
|
143,885
|
464,785
|
||||||
Accrued material purchases
|
107,396
|
--
|
||||||
Accrued professional fees
|
126,636
|
117,981
|
||||||
Accrued interest expense
|
10,907
|
296,344
|
||||||
Other
|
60,836
|
53,261
|
||||||
Total
|
$
|
1,195,317
|
$
|
1,804,485
|
|
December 31,
2016
|
March 31,
2016
|
||||||
Commerce Term Loan due January 2022
|
$
|
2,850,000
|
$
|
--
|
||||
People's Equipment Loan Facility due April 2021
|
3,031,046
|
--
|
||||||
Utica Credit Loan Note due November 2018
|
--
|
2,459,259
|
||||||
Revere Term Loan and Notes due January 2018
|
--
|
2,250,000
|
||||||
Obligations under capital lease
|
17,567
|
26,599
|
||||||
Total debt
|
$
|
5,898,613
|
$
|
4,735,858
|
||||
Less: Debt issue costs, unamortized
|
$
|
160,500
|
$
|
47,342
|
||||
Total debt, net
|
$
|
5,738,113
|
$
|
4,688,516
|
||||
Less: Current portion of long-term debt
|
$
|
696,245
|
$
|
953,106
|
||||
Long-term debt, net
|
$
|
5,041,868
|
$
|
3,735,410
|
|
Number Of
Options
|
Weighted
Average
Exercise Price
|
Aggregate
Intrinsic
Value
|
Weighted
Average
Remaining
Contractual Life
(in years)
|
||||||||||||
Outstanding at 3/31/2016
|
2,398,500
|
$
|
0.711
|
$
|
183,900
|
7.90
|
||||||||||
Granted
|
1,000,000
|
$
|
0.500
|
|||||||||||||
Expired
|
(440,000
|
)
|
$
|
0.912
|
||||||||||||
Outstanding at 12/31/2016
|
2,958,500
|
$
|
0.383
|
$
|
640,349
|
8.66
|
||||||||||
Vested or expected to vest at 12/31/2016
|
2,958,500
|
$
|
0.383
|
$
|
640,349
|
8.66
|
||||||||||
Exercisable and vested at 12/31/2016
|
1,958,500
|
$
|
0.451
|
$
|
373,163
|
8.37
|
|
Number of
Options
|
Weighted
Average
Exercise Price
|
||||||
Outstanding at 3/31/2016
|
1,028,334
|
$
|
0.117
|
|||||
Granted
|
1,000,000
|
$
|
0.500
|
|||||
Expired
|
(13,334
|
)
|
$
|
0.670
|
||||
Vested
|
(1,015,000
|
)
|
$
|
0.080
|
||||
Outstanding at 12/31/2016
|
1,000,000
|
$
|
0.250
|
Range of Exercise Prices:
|
Options
Outstanding
|
Weighted
Average
Remaining Contractual Term
|
Weighted
Average
Exercise Price
|
Options
Exercisable
|
Weighted
Average
Exercise Price
|
|||||||||||||||
$0.01-$1.00
|
2,770,000
|
8.37
|
$
|
0.30
|
1,770,000
|
$
|
0.33
|
|||||||||||||
$1.01-$1.96
|
188,500
|
0.29
|
$
|
1.59
|
188,500
|
$
|
1.59
|
|||||||||||||
Totals
|
2,958,500
|
1,958,500
|
|
December 31, 2016
|
March 31, 2016
|
||||||||||||||
Customer
|
Dollars
|
Percent
|
Dollars
|
Percent
|
||||||||||||
A
|
$
|
288,182
|
37
|
%
|
$
|
*
|
*
|
%
|
||||||||
B
|
$
|
128,053
|
17
|
%
|
$
|
*
|
*
|
%
|
||||||||
C
|
$
|
124,102
|
16
|
%
|
$
|
*
|
*
|
%
|
||||||||
D
|
$
|
109,662
|
14
|
%
|
$
|
225,415
|
11
|
%
|
||||||||
E
|
$
|
*
|
*
|
%
|
$
|
834,501
|
41
|
%
|
||||||||
F
|
$
|
*
|
*
|
%
|
$
|
315,699
|
16
|
%
|
|
Three Months
ended
December 31,
2016
|
Three Months
ended
December 31,
2015
|
Nine Months
ended
December 31,
2016
|
Nine Months
ended
December 31,
2015
|
||||||||||||
Basic EPS
|
||||||||||||||||
Net income
|
$
|
992,094
|
$
|
12,003
|
$
|
1,983,479
|
$
|
472,960
|
||||||||
Weighted average number of shares outstanding
|
28,156,115
|
27,324,593
|
27,602,775
|
26,084,080
|
||||||||||||
Basic income per share
|
$
|
0.03
|
$
|
0.00
|
$
|
0.07
|
$
|
0.02
|
||||||||
Diluted EPS
|
||||||||||||||||
Net income
|
$
|
992,094
|
$
|
12,003
|
$
|
1,983,479
|
$
|
472,960
|
||||||||
Dilutive effect of stock options, warrants and preferred stock
|
717,122
|
185,387
|
658,335
|
126,126
|
||||||||||||
Diluted weighted average shares
|
28,873,237
|
27,509,980
|
28,261,110
|
26,210,206
|
||||||||||||
Diluted income per share
|
$
|
0.03
|
$
|
0.00
|
$
|
0.07
|
$
|
0.02
|
(
dollars in thousands)
|
Three Months Ended
December 31, 2016
|
Three Months Ended
December 31, 2015
|
Changes from
2016 to 2015
|
|||||||||||||||||||||
|
Amount
|
Percent
|
Amount
|
Percent
|
Amount
|
Percent
|
||||||||||||||||||
Net sales
|
$
|
5,319
|
100
|
%
|
$
|
3,507
|
100
|
%
|
$
|
1,812
|
52
|
%
|
||||||||||||
Cost of sales
|
3,267
|
61
|
%
|
2,435
|
69
|
%
|
832
|
34
|
%
|
|||||||||||||||
Gross profit
|
2,052
|
39
|
%
|
1,072
|
31
|
%
|
980
|
91
|
%
|
|||||||||||||||
Selling, general and administrative
|
1,955
|
37
|
%
|
768
|
22
|
%
|
1,187
|
nm
|
% | |||||||||||||||
Gain from claims assignment settlement
|
(1,122
|
)
|
21
|
%
|
--
|
--
|
%
|
(1,122
|
)
|
nm
|
% | |||||||||||||
Income from operations
|
1,219
|
23
|
%
|
304
|
9
|
%
|
915
|
nm
|
% | |||||||||||||||
Other income
|
1
|
--
|
%
|
--
|
--
|
%
|
1
|
--
|
%
|
|||||||||||||||
Interest expense
|
(207
|
)
|
(4
|
)%
|
(292
|
)
|
(8
|
)%
|
85
|
29
|
%
|
|||||||||||||
Total other expense, net
|
(206
|
)
|
(4
|
)%
|
(292
|
)
|
(8
|
)%
|
86
|
29
|
%
|
|||||||||||||
Income before income taxes
|
1,013
|
19
|
%
|
12
|
--
|
%
|
1,001
|
nm
|
% | |||||||||||||||
Income tax expense
|
21
|
--
|
%
|
--
|
--
|
%
|
21
|
nm
|
% | |||||||||||||||
Net income
|
$
|
992
|
19
|
%
|
$
|
12
|
--
|
%
|
$
|
980
|
nm
|
% |
|
December 31, 2016
|
December 31, 2015
|
$ Change
|
% Change
|
||||||||||||
Other income
|
$
|
1,130
|
$
|
471
|
$
|
659
|
nm
|
%
|
||||||||
Interest expense
|
$
|
(157,112
|
)
|
$
|
(213,188
|
)
|
$
|
56,076
|
26
|
%
|
||||||
Interest expense: non-cash
|
$
|
(50,409
|
)
|
$
|
(78,720
|
)
|
$
|
28,311
|
36
|
%
|
|
Nine Months Ended
December 31, 2016
|
Nine Months Ended
December 31, 2015
|
Changes from
2016 to 2015
|
|||||||||||||||||||||
(dollars in thousands)
|
Amount
|
Percent
|
Amount
|
Percent
|
Amount
|
Percent
|
||||||||||||||||||
Net sales
|
$
|
13,620
|
100
|
%
|
$
|
11,985
|
100
|
%
|
$
|
1,635
|
14
|
%
|
||||||||||||
Cost of sales
|
8,559
|
63
|
%
|
8,223
|
69
|
%
|
336
|
4
|
%
|
|||||||||||||||
Gross profit
|
5,061
|
37
|
%
|
3,762
|
31
|
%
|
1,299
|
35
|
%
|
|||||||||||||||
Selling, general and administrative
|
3,583
|
26
|
%
|
2,482
|
21
|
%
|
1,101
|
44
|
%
|
|||||||||||||||
Gain from claims assignment settlement
|
(1,122
|
)
|
8
|
%
|
--
|
--
|
%
|
(1,122
|
)
|
nm
|
% | |||||||||||||
Income from operations
|
2,600
|
19
|
%
|
1,280
|
11
|
%
|
1,320
|
103
|
%
|
|||||||||||||||
Other income
|
9
|
--
|
%
|
1
|
--
|
%
|
8
|
nm
|
% | |||||||||||||||
Interest expense
|
(584
|
)
|
(4
|
)%
|
(808
|
)
|
(7
|
)%
|
224
|
28
|
%
|
|||||||||||||
Total other expense, net
|
(575
|
)
|
(4
|
)%
|
(807
|
)
|
(7
|
)%
|
232
|
29
|
%
|
|||||||||||||
Income before income taxes
|
2,025
|
15
|
%
|
473
|
4
|
%
|
1,552
|
nm
|
% | |||||||||||||||
Income tax expense
|
42
|
--
|
%
|
--
|
--
|
%
|
42
|
nm
|
% | |||||||||||||||
Net income
|
$
|
1,983
|
15
|
%
|
$
|
473
|
4
|
%
|
$
|
1,510
|
nm
|
% |
|
December 31,
2016
|
December 31,
2015
|
$ Change
|
% Change
|
||||||||||||
Other income
|
$
|
8,705
|
$
|
1,561
|
$
|
7,144
|
nm
|
% | ||||||||
Interest expense
|
$
|
(443,541
|
)
|
$
|
(525,450
|
)
|
$
|
81,909
|
16
|
%
|
||||||
Interest expense: non-cash
|
$
|
(140,458
|
)
|
$
|
(282,759
|
)
|
$
|
142,301
|
50
|
%
|
(dollars in thousands)
|
December 31,
2016
|
March 31,
2016
|
Change
|
|||||||||
Cash
|
$
|
3,795
|
$
|
1,332
|
$
|
2,463
|
||||||
Working capital
|
$
|
4,996
|
$
|
510
|
$
|
4,486
|
||||||
Total debt
|
$
|
5,899
|
$
|
4,736
|
$
|
1,163
|
||||||
Total stockholders' equity
|
$
|
4,803
|
$
|
1,728
|
$
|
3,075
|
(dollars in thousands)
|
December 31,
2016
|
December 31,
2015
|
Change
|
|||||||||
Cash flows provided by (used in):
|
||||||||||||
Operating activities
|
$
|
1,912
|
$
|
373
|
$
|
1,539
|
||||||
Investing activities
|
(453
|
)
|
(192
|
)
|
(261
|
)
|
||||||
Financing activities
|
1,004
|
(700
|
)
|
1,704
|
||||||||
Effects of foreign exchange rates on cash
|
--
|
(1
|
)
|
1
|
||||||||
Net increase (decrease) in cash
|
$
|
2,463
|
$
|
(520
|
)
|
$
|
2,983
|
Exhibit No.
|
Description
|
10.1
|
Loan Agreement, dated December 20, 2016, by and between Ranor, Inc. and Commerce Bank & Trust Company.
|
10.2
|
Amendment, dated December 20, 2016, to Master Loan and Security Agreement No. 4180, dated as of March 31, 2016, by and between People's Capital and Leasing Corp. and Ranor, Inc.
|
10.3
|
Non-Qualified Stock Option Award Agreement, dated as of December 27, 2016, from TechPrecision Corporation to Alexander Shen.
|
10.4
†
|
|
31.1
|
|
31.2
|
|
32.1
|
|
101.INS
|
101.INS XBRL Instance Document
|
101.SCH
101.CAL
101.LAB
101.PRE
101.DEF
|
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB XBRL Taxonomy Extension Labels Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
|
†
|
Management contract or compensatory arrangement or plan.
|
|
TECHPRECISION CORPORATION
|
|
|
|
|
Dated: February 14, 2017
|
By:
|
/s/ Thomas Sammons
|
|
|
Thomas Sammons
Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
Exhibit No.
|
Description
|
10.4
†
|
|
31.1
|
|
31.2
|
|
32.1
|
|
101.INS
|
101.INS XBRL Instance Document
|
101.SCH
101.CAL
101.LAB
101.PRE
101.DEF
|
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB XBRL Taxonomy Extension Labels Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
|
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
|
|
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
|
|
|
c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
|
|
|
d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
|
|
|
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Dated: February 14, 2017
|
/s/ Alexander Shen
|
|
Alexander Shen
Chief Executive Officer
|
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
|
|
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
|
|
|
c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
|
|
|
|
d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
|
|
|
|
|
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
|
|
|
||
|
|
||
Dated: February 14, 2017
|
/s/ Thomas Sammons
|
||
|
Thomas Sammons
|
||
|
Chief Financial Officer
|
Dated: February 14, 2017
|
/s/ Alexander Shen
|
|
Alexander Shen
|
|
Chief Executive Officer
|
|
|
Dated: February 14, 2017
|
/s/ Thomas Sammons
|
|
Thomas Sammons
Chief Financial Officer
|
|
|